Who Owns Evolus Stock?
NASDAQ: EOLSHealthcareDrug Manufacturers - Specialty & GenericUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 77.74%
- Held by insiders
- 11.25%
- Institutional holders
- 201
- Institutions 77.7%
- Insiders 11.2%
- Public and other 11.0%
Who owns Evolus stock?
Institutional investors own about 77.7% of Evolus's shares, spread across 201 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 11.25% of EOLS.
The largest institutional holders are Nantahala Capital Management, LLC (8.48%), Blackrock Inc. (7.33%) and Braidwell LP (4.78%). Together, the top 10 institutions control 42.0% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their EOLS positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of EOLS
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Nantahala Capital Management, LLC | 5.60M | 8.48% | -12.2% |
| Blackrock Inc. | 4.84M | 7.33% | +12.8% |
| Braidwell LP | 3.16M | 4.78% | +1.6% |
| Frazier Life Sciences Management, L.P. | 2.63M | 3.98% | 0.0% |
| Perceptive Advisors Llc | 2.46M | 3.72% | +91.1% |
| Vanguard Capital Management LLC | 2.36M | 3.58% | -4.3% |
| Millennium Management Llc | 1.79M | 2.71% | +22.4% |
| State Street Corporation | 1.70M | 2.57% | +28.5% |
| Geode Capital Management, LLC | 1.61M | 2.44% | +16.4% |
| Stonepine Capital Management, LLC | 1.59M | 2.41% | -9.6% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of EOLS
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.54M | 2.34% |
| iShares Trust-iShares Russell 2000 ETF | 1.52M | 2.29% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 770.28K | 1.17% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 645.69K | 0.98% |
| iShares Trust-iShares Russell 2000 Growth ETF | 561.93K | 0.85% |
| SPDR SERIES TRUST-State Street SPDR S&P Pharmaceuticals ETF | 443.20K | 0.67% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 328.49K | 0.50% |
| SCHWAB STRATEGIC TRUST-Schwab U.S. Small-Cap ETF | 309.04K | 0.47% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 287.80K | 0.44% |
| iShares Trust-iShares U.S. Pharmaceuticals ETF | 239.52K | 0.36% |
Frequently asked questions
Who is the largest shareholder of Evolus?
Nantahala Capital Management, LLC is the largest institutional shareholder of EOLS, owning 8.48% of shares outstanding (5.60M shares) as of its latest 13F filing.
What percentage of Evolus is owned by institutions?
Institutions own about 77.7% of EOLS shares and 87.6% of the public float.
How much of Evolus do insiders own?
Insiders, such as officers and directors, own about 11.25% of EOLS shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.